Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Preclinical models highlight ACE2's protective RAS role; leaves open whether augmentation improves human cardiovascular outcomes.
Tikellis et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: